Ruta Pumputiene’s Law Firm, operating primarily in the field of life sciences and regulatory practice in the Baltics, has joined Ellex Valiunas.
According to Ellex, this merger was driven by “the priority of both firms for the development of the life sciences sector and a significantly increased need for pharmaceutical and life sciences law.”
As Ellex Valiunas puts it, Pumputiene, who became the 20th Partner at the Lithuanian firm, is “one of the most valued experts in life sciences, healthcare, biotechnology, and pharmaceutical law."
“I am delighted that both my team and I will be able to continue our professional career in this field, only having even wider, bigger, more diverse, and more interesting opportunities with Ellex,” Pumputiene says. “The professional path must always advance and lead only forward. I believe that by sharing our knowledge, together we will be able to offer our clients and their projects the highest, exceptional expertise and quality, which is the aspiration and the main goal of us all.”
“The demand for life sciences has grown enormously in recent years as the pandemic made the world realize a long-term perspective in this area,” comments Managing Partner Rolandas Valiunas. “Ruta and her colleagues have been leaders in the life sciences area for many years, and this merger of our firms will open new avenues for the industry planning additional business steps in the Baltics. But most importantly, our alumni are coming back. Ruta had contributed to Ellex’s growth and strengthening for ten years, and while she was practicing elsewhere, we sincerely missed her.”
Joining alongside Pumputiene are her team members – Lawyers Ieva Balene, Giedre Tubelyte, and Viktorija Kod.